Clinical Research
Rethinking Evidence for Psychedelics in Medicine
According to popular accounts, the U.S. Drug Enforcement Administration’s (DEA) scheduling of LSD and other psychedelics in 1968 shut down promising research for decades.
Rethinking Evidence for Psychedelics in Medicine
